Revolutionizing Biotech: Accelerate Development with AI-Powered Predictive Analysis!

"QBDC’s ML/AI prediction algorithm significantly shortes development times."

Karlheinz Landauer Book Appointment
Founder & CEO of QBDC Austria

By predicting fed-batch experiment outcomes without performing them, we save time and costs, enhance process knowledge, and ensure robust, reproducible processes.

This is supporting Quality by Design and reducing the need for extensive characterization studies.

Development Time

-50%

Development Costs

- 30%

Process Robustness

+ 100%

Partner with Us for Faster, Cost-Effective Biotech Development

Our partnership is dedicated to accelerating development timelines by harnessing the power of DNA methylation analysis alongside QBDC’s advanced ML/AI prediction algorithm. By leveraging these innovative technologies, we can forecast the outcomes of fed-batch experiments without the need for actual execution. Our high-throughput systems meticulously analyze shifts in DNA methylation patterns, allowing us to validate media components, additives, and feeding strategies at an early stage.

This data-driven approach ensures that we build robust and reproducible processes from the outset. The outcome is a thorough report that outlines potential adjustments and their effects on product quality. By adopting this proactive methodology, we not only save valuable time and reduce costs, but we also deepen our understanding of the process. Furthermore, it supports our commitment to Quality by Design as we prepare for the future Process Performance Qualification (PPQ), minimizing the requirement for extensive characterization studies.

Together, we are paving the way for a more efficient and effective development process, and I encourage you to embrace these advancements as we move forward.

Book Appointment

Accelerated Development

Reduce time and resources needed for process development.

Enhanced Predictability

Predict outcomes of fed-batch experiments without performing them.

Cost Efficiency

Save costs by leveraging data and reducing the need for extensive wet-lab experiments.

CMC Consulting

We ensure compliance with regulatory standards, optimizes product development, and enhances manufacturing processes, ultimately leading to high-quality, safe, and effective biopharmaceutical products.

Control of Product and Raw Material Quality

We utilize high-throughput systems and DNA methylation analysis to define critical raw materials early. This proactive approach reduces costs and resources.

Scaling and Transfer Comparability

We’ve created a comparison report on potential changes and their impacts on product quality. Ultimately, it equips our clients with the tools to uphold high standards in bioprocessing.